RECRUITING

Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment

Talk to us

Conditions

Congenital Heart DiseaseCongenital Heart Disease (CHD)

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators want to study the correlation of having a 3D printed model with improvement in patient outcomes and compare those with patients who have had a VAD placement without a 3D model.

Official Title

Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment

Quick Facts

Study Start:2020-01-22
Study Completion:2027-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03891160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who weigh over 3 kilograms with CHD HF who are candidates for MCS will be prospectively identified at the participating centers.
  1. * Any CHD-HF patient unable to tolerate a CMR or cardiac CT will be excluded.

Contacts and Locations

Study Contact

Kanwal Farooqi, MD
CONTACT
212-305-8509
kf2549@cumc.columbia.edu
Katrina Golub, MPH
CONTACT
212-342-1562
kg2697@cumc.columbia.edu

Principal Investigator

Kanwal Farooqi, MD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Children's National Hospital
Washington, District of Columbia, 20010
United States
University of Florida
Gainesville, Florida, 32610
United States
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322
United States
Lurie Children's Hospital
Chicago, Illinois, 60611
United States
University of Iowa
Iowa City, Iowa, 52242
United States
Johns Hopkins
Baltimore, Maryland, 21287
United States
Washington University
Saint Louis, Missouri, 63110
United States
Montefiore Medical Center
Bronx, New York, 10467
United States
Columbia University
New York, New York, 10032
United States
Weill Cornell
New York, New York, 10065
United States
Duke University
Durham, North Carolina, 27710
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
University of Virginia
Charlottesville, Virginia, 22903
United States
Seattle childrens
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Kanwal Farooqi, MD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-22
Study Completion Date2027-07-31

Study Record Updates

Study Start Date2020-01-22
Study Completion Date2027-07-31

Terms related to this study

Keywords Provided by Researchers

  • Congenital Heart Disease (CHD)

Additional Relevant MeSH Terms

  • Congenital Heart Disease